A novel chitosan-peptide system for cartilage tissue engineering with adipose-derived stromal cells

Le résumé fourni par la source

The natural healing process of cartilage injuries often fails to fully restore the tissue’s biological and mechanical functions. Cartilage grafts are costly and require surgical intervention, often associated with complications such as intraoperative infection and rejection by the recipient due to ischemia. Novel tissue engineering technologies aim to ideally fill the cartilage defect to prevent disease progression or regenerate damaged tissue. Despite many studies on designing biocompatible composites to stimulate chondrogenesis, only few focus on peptides and carriers that promote stem cell proliferation or differentiation to promote healing. Our research aimed to design a carbohydrate chitosan-based biomaterial to stimulate stem cells into the chondrogenesis pathway. Our strategy was to combine chitosan with a novel peptide (UG28) that sequence was based on the copin protein. The construct stimulated human adipose-derived stem cells (AD-SCs) cells to undergo chondrogenic differentiation. Chitosan 75/500 allows AD-SCs to grow and has no harmful effects on the cells. The combination of UG28 peptide with the chitosan composite offers promising properties for cell differentiation, indicating its potential for clinical applications in cartilage regeneration. • Copin family peptide UG 28 effectively stimulates the differentiation of AD-SCs into chondrocytes. • Chitosan substrates are biocompatible and safe for cell applications. • Chitosan membranes serve as effective carriers for cells and bioactive compounds in cartilage repair. • Peptides and chitosan membranes enhance the regenerative potential of AD-SCs for cartilage therapies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.